Login
$GILD
$169.15 +$1.57 (0.94%) After hours

$GILD 8-K/A SEC Filings

Filed On Filing
13 Dec 2024 8-K/A: Departure/Election of Directors or Officers; Compensation

Foster City, Calif., Dec. 12, 2024 – Gilead Sciences, Inc. (Nasdaq: GILD) today announced that Dietmar Berger, MD, PhD, will join the company on January 2, 2025, as Chief Medical Officer and will become a member of Gilead’s senior leader...

06 Jan 2021 8-K/A: Completion of Acquisition or Disposition of Assets

The following unaudited pro forma condensed combined financial information is presented to illustrate the estimated effect of the acquisition by Gilead Sciences, Inc., a Delaware corporation (“Gilead” or “Parent”) of Immunomedics, Inc., ...

18 May 2017 8-K/A: Submission of Matters to a Vote of Security Holders

(d) At the Annual Meeting, the Company’s stockholders voted, among other matters, on an advisory basis, as to the frequency with which executive compensation will be subject to future advisory stockholder votes. As previously reported in...

25 Jul 2016 8-K/A: Results of Operations and Financial Condition

Foster City, CA, July 25, 2016 - Gilead Sciences, Inc. (Nasdaq: GILD) announced today its results of operations for the second quarter ended June 30, 2016. The financial results that follow represent a year-over-year comparison of second...

22 Mar 2012 8-K/A: Completion of Acquisition or Disposition of Assets

The unaudited pro forma combined financial statements presented below are based on, and should be read in conjunction with (i) the historical consolidated financial statements for Gilead Sciences, Inc. (“Gilead”) included in its Annual R...

17 Jul 2009 8-K/A: Entry into a Material Definitive Agreement

On July 16, 2009, Gilead Sciences, Inc. (Gilead) filed a Current Report on Form 8-K (the Original Report) disclosing that Gilead and its wholly owned subsidiary, Gilead Sciences Limited, entered into a License and Collaboration Agreement...

14 Aug 2008 8-K/A: Departure/Election of Directors or Officers; Compensation

On August 5, 2008, Gilead Sciences, Inc. (the Company) filed a Form 8-K disclosing that the Company’s Board of Directors (the Board) had elected Richard J. Whitley, MD to serve as a member of the Board effective July 30, 2008. The Compan...

10 May 2007 8-K/A: Departure/Election of Directors or Officers; Compensation

Gilead Sciences, Inc. (the Company) is filing this amendment to its Current Report on Form 8-K, filed with the Securities and Exchange Commission (the SEC) on January 23, 2007 and amended by its Amendment to Current Report on Form 8-K/A ...

09 Feb 2007 8-K/A: Departure/Election of Directors or Officers; Compensation

Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangement of Certain Officers.

01 Feb 2007 8-K/A: Completion of Acquisition or Disposition of Assets

We hereby consent to the incorporation by reference in the Registration Statements filed by Gilead Sciences, Inc. on Form S-8 for the Myogen, Inc. 2003 Equity Incentive Plan (No. 333-138985), Form S-8 for the Corus Pharma, Inc. 2001 Stoc...

22 Feb 2006 8-K/A: Entry into a Material Definitive Agreement

The Gilead Sciences, Inc. Severance Plan (the “Plan”) was adopted by the Company effective January 29, 2003 and amended and restated on March 23, 2004. The Plan was subsequently amended on May 9, 2005. The Plan replaces all severance or ...

01 Feb 2006 8-K/A: Departure/Election of Directors or Officers; Compensation

On December 12, 2005, Gilead Sciences, Inc. filed a Current Report on Form 8-K to report that John W. Madigan had been appointed to serve on Gilead’s Board of Directors. At the time of his appointment, the Board of Directors had not yet ...

08 May 2003 8-K/A: Completion of Acquisition or Disposition of Assets

Pursuant to Section 906 of the Public Company Accounting Reform and Investor Protection Act of 2002 (18 U.S.C. § 1350, as adopted), John C. Martin, the Chief Executive Officer of Gilead Sciences, Inc. (the “Company”), and John F. Milliga...

13 Mar 2003 8-K/A: Completion of Acquisition or Disposition of Assets

Consolidated Balance Sheets as of December 31, 2002 and 2001

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support